Complementary and Alternative Medicines Use by Cancer Patients and the Role of the Drug Information Pharmacist

2012 ◽  
Vol 42 (3) ◽  
pp. 181-183
Author(s):  
James D Mellor ◽  
Julie Sanders ◽  
Arti Thakerar
2020 ◽  
Vol 13 (1) ◽  
pp. 227-231
Author(s):  
Pooja M.R. ◽  
Pushpalatha M.P.

Background: Clinicians and physicians need to be aware of the high prevalence of complementary and alternative medicines use in patients with asthma, as it is found to be associated with lack of asthma control, though the degree to which associations exist is still not clear. Methods: We have performed a cluster analysis to characterize patterns defining different asthma control levels and the extent to which the medicines have an impact in these categories. Results and Conclusion: We have explored the association of Complementary and Alternative medicines utilization with asthma control and the effect of asthma controller medications, with the conclusion that the usage of complementary and alternative medicines does not have a significant impact on partially and uncontrolled asthmatics.


Oncology ◽  
2019 ◽  
Vol 97 (1) ◽  
pp. 18-25 ◽  
Author(s):  
Mathilde Gras ◽  
Alexis Vallard ◽  
Christelle Brosse ◽  
Aurélie Beneton ◽  
Sandrine Sotton ◽  
...  

2012 ◽  
Vol 18 (4) ◽  
pp. 252-256 ◽  
Author(s):  
Maryam Farooqui ◽  
Mohamed Azmi Hassali ◽  
Aishah Knight Abdul Shatar ◽  
Asrul Akmal Shafie ◽  
Muhammad Aslam Farooqui ◽  
...  

Author(s):  
Sharifah Nadia Syed Mohammad Salleh ◽  
Maryam Farooqui ◽  
Shubashini Gnanasan ◽  
Mahmathi Karuppannan

Abstract Objectives Chemotherapy-related side effects (CRSE) are among the most distressing events cancer patients face. Some patients seek complementary and alternative medicines (CAM), increasing the risk of undesirable drug- CAM interactions. This study aims to identify the prevalence and type of CAM used for CRSE among cancer patients and patient’s disclosure of CAM use to their prescribers. Methods This was a questionnaire-based, cross-sectional study. Data was collected from cancer patients attending to three departments: surgical, medical and gynaecology at a local hospital in Malaysia. Ethical approval was obtained from the Medical Research Ethics Committee, Ministry of Health, Malaysia. Results A total of 273 patients were recruited. Prevalence of CAM used for CRSE management was 166 (60.8%). Of the CAM users, 144 (86.7%) were female, 102 (61.4%) were employed and 123 (74.1%) were married. Breast cancer patients were found to be the highest users of CAM (n=76; 45.8%). The top three CAM used by patients in managing CRSE were dietary supplements (n=166; 100%); herbal products (n=154; 92.8%) and traditional Malay therapy (n=147; 88.6%). About 83% (n=137) patients disclosed CAM use to their prescribers. Among these, 58 (42.3%) reported that their doctors encouraged the use, whereas 89 (65.0%) patients claimed their doctors disagreed the use of CAM. Conclusions Prescribers still have doubt in combining chemotherapy with CAM, hence patients use CAM discreetly. Increasing the awareness and understanding of CAM use are mandatory to distinguish its possible synergistic or adverse reactions with cancer patients.


Sign in / Sign up

Export Citation Format

Share Document